evalu
aetiolog
agent
epidemiolog
featur
sever
fever
thrombocytopenia
syndrom
sft
hubei
provinc
china
sera
patient
collect
januari
decemb
case
occur
april
decemb
epidem
peak
may
august
age
patient
rang
year
median
year
incid
sft
increas
age
femal
male
ratio
case
case
confirm
qpcr
sftsv
hantaviru
hv
infect
respect
case
simultan
infect
two
pathogen
found
research
paper
show
suspect
sft
case
confus
hv
infect
due
similar
symptom
analysi
show
distribut
sftsv
mark
region
aggreg
hubei
provinc
begin
march
sever
fever
thrombocytopenia
syndrom
sft
detect
hilli
region
hubei
provinc
central
china
howev
caus
sft
unclear
primari
clinic
manifest
patient
sft
suddenonset
fever
thrombocytopenia
leukocytopenia
gastrointestin
symptom
led
diseas
assign
name
sft
first
mortal
rate
infecti
diseas
reach
yu
et
al
subsequ
case
report
henan
shandong
jiangsu
liaon
provinc
china
clinic
symptom
similar
human
granulocyt
anaplasmosi
hga
patient
symptom
hubei
abbrevi
sft
sever
fever
thrombocytopenia
syndrom
sftsv
sever
fever
thrombocytopenia
syndrom
viru
hv
hantaviru
qpcr
quantit
realtim
polymeras
chain
reaction
elisa
enzymelink
immunosorb
assay
ck
creatin
kinas
ldh
lactat
dehydrogenas
alt
alanin
aminotransferas
ast
aspart
aminotransferas
htnv
hantaan
viru
sar
acut
respiratori
syndrom
hga
human
granulocyt
anaplasmosi
provinc
initi
diagnos
hga
yu
et
al
xu
et
al
case
laboratori
evid
insuffici
verifi
diagnosi
chines
center
diseas
control
prevent
cdc
state
symptom
compat
hga
describ
unit
state
wellman
et
al
march
new
viru
isol
patient
blood
chines
cdc
name
sft
bunyaviru
sftsv
li
aetiolog
investig
diseas
undertaken
hubei
cdc
accord
clinic
characterist
case
definit
surveil
sft
initi
hubei
provinc
evalu
aetiolog
epidemiolog
sft
enhanc
surveil
acut
febril
ill
carri
hubei
provinc
surveil
network
town
health
centr
gener
hospit
establish
hubei
provinc
fig
symptom
includ
primarili
acut
fever
c
thrombocytopenia
platelet
count
unknown
caus
fever
bleed
tendenc
includ
melena
bleed
gum
skin
point
spot
congest
conjunctiva
liu
et
al
collect
blood
sampl
hospitalis
patient
whose
symptom
met
criteria
case
definit
exclud
patient
whose
symptom
met
criteria
anoth
clinicalor
diagnosi
suspect
case
exhibit
one
follow
symptom
isol
viru
serum
viral
rna
acutephas
serum
least
fourfold
increas
immunoglobulin
g
igg
titr
pair
sera
convalesc
acut
phase
detect
elisa
immunoglobulin
igm
serum
viral
rna
extract
serum
use
qiaamp
viral
rna
mini
kit
qiagen
cutoff
cycl
threshold
posit
sampl
cycl
extract
rna
use
templat
rtpcr
amplifi
sftsv
rna
use
primer
deriv
small
rna
srna
segment
viru
wen
et
al
rtpcr
perform
use
onestep
pcr
kit
takara
pcr
product
sequenc
confirm
presenc
sftsv
histag
affin
chromatographypurifi
recombin
nucleocapsid
protein
np
sft
v
strain
express
escherichia
coli
use
antigen
niu
et
al
macelisa
use
detect
specif
igmg
elisaigmg
kit
key
laboratori
medic
virolog
cdc
igm
hantaviru
hv
detect
elisa
beij
wantai
compani
confirm
qpcr
shanghai
zhijiang
compani
tabl
infect
hga
detect
qpcr
dana
gene
compani
brucella
detect
plate
agglutin
test
pat
confirm
standard
tube
agglutin
test
sat
case
sft
report
counti
district
hubei
provinc
fig
morbid
case
fatal
rate
respect
annual
incid
sft
increas
age
x
p
patient
year
age
account
total
number
case
farmer
account
fig
femal
male
ratio
confirm
case
sftsv
infect
hubei
provinc
case
occur
april
decemb
fig
epidem
peak
april
august
total
sft
case
counti
district
hubei
provinc
laboratoryconfirm
confirm
case
dabi
mountain
area
adjac
henan
anhui
provinc
major
clinic
featur
patient
confirm
sftsv
infect
suddenonset
sever
fever
day
durat
accompani
malais
fatigu
elderli
patient
poor
health
high
blood
pressur
diabet
high
blood
lipid
level
tend
poorer
outcom
clinic
laboratori
manifest
includ
fever
malais
thrombocytopenia
leucopenia
tabl
creatin
kinas
ck
lactat
dehydrogenas
ldh
level
major
case
higher
togeth
haematuria
proteinuria
suggest
rapid
progress
multipl
organ
failur
major
clinic
symptom
patient
fever
leukocytopenia
thrombocytopenia
togeth
abnorm
alanin
aminotransferas
alt
aspart
aminotransferas
ast
calcium
ldh
level
tabl
total
sft
case
analys
qpcr
posit
rate
pcr
amplif
segment
pcr
product
confirm
sftsv
rna
sequenc
consist
detect
qpcr
elisaigm
tabl
sensit
calcul
combin
qpcr
elisa
result
acutephas
serum
sampl
denomin
sensit
elisa
qpcr
abbrevi
p
postiv
n
neg
percentag
case
whose
level
platelet
count
increas
case
whose
platelet
count
elev
level
case
whose
result
platelet
count
avail
mean
follow
data
similar
posit
sftsv
qpcr
posit
igm
sftsv
elisaigm
signific
differ
assay
perform
sampl
obtain
one
two
week
initi
ill
x
p
also
detect
anaplasma
phagocytophilum
hantaviru
brucella
total
number
case
diagnos
sftsv
infect
diagnos
igm
hantaviru
hv
confirm
qpcr
hv
infect
genotyp
hv
hantaan
viru
htnv
case
simultan
infect
two
pathogen
found
moreov
evid
hga
brucella
infect
found
patient
result
suggest
case
symptom
sft
may
caus
hv
therefor
underli
caus
sft
diagnos
interpret
caution
follow
sever
acut
respiratori
syndrom
sar
epidem
chines
govern
focus
establish
infecti
diseas
surveil
report
system
facilit
identif
known
unknown
diseas
among
prefecturallevel
citi
hubei
provinc
includ
counti
district
report
sft
case
investig
perform
identifi
whether
sft
caus
pathogen
clinic
symptom
resembl
human
anaplasmosi
brucellosi
hemorrhag
fever
hfr
neither
specif
nucleotid
antibodi
pathogen
could
detect
blood
sampl
major
patient
instead
sftsv
hantaviru
hv
detect
patient
blood
sft
case
hubei
provinc
sftsv
infect
hv
none
hga
sftsv
major
aetiolog
agent
sft
hubei
provinc
howev
case
hv
suggest
suspect
sft
case
confus
hv
infect
due
similar
symptom
signific
differ
clinic
symptom
patient
confirm
hv
infect
confirm
sftsv
infect
signific
differ
clinic
symptom
laboratoryconfirm
unconfirm
case
x
p
differ
symptom
laboratoryconfirm
sftsv
test
thrombocytopenia
leukopenia
laboratoryunconfirm
sftsv
test
respect
tabl
result
help
accur
diagnos
sft
conclud
sftsv
long
epidem
hubei
provinc
clinic
symptom
case
ident
anaplasma
infect
found
haemaphyali
longicorni
hubei
provinc
zhang
et
al
report
henan
provinc
china
show
sft
case
evid
hga
xu
et
al
infect
anaplasma
phagocytophilum
suggest
caus
pathogen
detect
laboratori
test
major
patient
hubei
provinc
suggest
sftsv
may
caus
subclin
infect
children
adult
moreov
cytopath
effect
sftsv
modest
vero
cell
render
detect
problemat
therefor
distribut
sftsv
hga
infect
hubei
p
rovinc
investig
number
case
increas
gradual
april
septemb
tick
densiti
highest
tesh
schmaljohn
hjell
chang
tick
densiti
associ
number
confirm
sftsv
case
klompen
et
al
therefor
tick
may
transmit
viru
render
diseas
danger
sftsv
isol
tick
chines
cdc
moreov
persontoperson
blood
transmiss
sftsv
report
bao
et
al
gai
et
al
jiang
et
al
sftsv
case
hubei
provinc
show
abnorm
ast
alt
level
major
case
exhibit
elev
ck
ldh
level
combin
haematuria
proteinuria
indic
multipl
organ
could
infect
sftsv
understood
caus
sftsv
novel
bunyaviru
found
china
main
caus
death
clinic
practic
yet
clear
mechan
blood
transmiss
also
unclear
possibl
includ
bleed
viru
replic
rate
high
viral
load
research
matter
warrant
sftsv
posit
rate
qpcr
higher
acutephas
blood
sampl
obtain
first
week
second
week
tabl
howev
sftsv
igm
posit
rate
show
opposit
result
find
support
use
qpcr
serum
sampl
confirm
detect
sftsv
first
week
ill
onset
serum
elisa
detect
second
week
result
also
suggest
elisa
qpcr
alon
insuffici
sensit
diagnosi
sftsv
infect
earli
stage
sft
combin
qpcr
elisa
result
increas
sensit
markedli
end
case
sft
mainli
distribut
eastern
central
china
henan
provinc
hubei
provinc
anhui
provinc
shandong
provinc
jiangsu
provinc
liaon
provinc
zhejiang
provinc
highest
incid
sft
hubei
compar
provinc
rang
per
per
howev
highest
incid
sft
henan
hubei
china
sinc
incid
sft
increas
annual
hubei
henan
shandong
greatest
incid
henan
provinc
second
highest
hubei
provinc
china
fig
sft
new
acut
infecti
diseas
infect
sftsv
distribut
throughout
hubei
provinc
howev
major
qpcrconfirm
case
dabi
mountain
area
hubei
provinc
adjac
henan
provinc
anhui
provinc
dabi
mountain
area
locat
hubei
henan
anhui
provinc
suggest
cluster
distribut
sftsv
infect
